Clinical Study
Troxipide in the Management of Gastritis: A Randomized Comparative Trial in General Practice
Table 1
Baseline demographic and clinical characteristics of study population.
| | Troxipide | Ranitidine |
| | Sex (, %) | | | | Male | 46 (64.78) | 35 (49.30) | | Female | 25 (35.21) | 36 (50.70) | | Age (yrs), mean (±SD) | | | | Body mass index (kg/m2), mean (±SD) | | | | Positive H. pylori urea breath test | 5 (7.04) | 0 (0.0) | | Endoscopic site of Gastritis (, %) | | | | Antrum | 19 (26.76) | 30 (42.25) | | Corpus | 7 (9.86) | 6 (8.45) | | Antrum and Corpus (Pangastritis) | 45 (63.38) | 33 (46.47) | | Endoscopic Evidences (, %) | | | | Erosion | 59 (83.1) | 55 (77.46) | | Oozing | 31 (43.66) | 19 (26.76) | | Redness | 67 (94.36) | 63 (88.73) | | Edema | 49 (69.01) | 43 (60.56) | | Gastritis clinical symptoms (, %) | | | | Abdominal Pain | 71 (100.0) | 71 (100.0) | | Bloating | 67 (94.36) | 65 (91.55) | | Belching | 44 (61.97) | 39 (54.93) | | Nausea | 51 (71.83) | 50 (70.42) | | Vomiting | 14 (19.72) | 13 (18.31) | | Loss of appetite | 29 (40.85) | 22 (30.99) | | Heartburn | 58 (81.69) | 49 (69.01) |
|
|
